• COVID-19
  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

FDA Clears First-in-World Hematology App, Unlocking Potential of Diagnosis

by Jasmine Pennic 10/23/2020 Leave a Comment

FDA Clears First-in-World Hematology App, Unlocking Potential of Diagnosis

What You Should Know:

– Scopio Labs announced FDA clearance of its AI-powered X100 microscope and decision support system with Full Field Peripheral Blood Smear (Full Field PBS) application. 

– Using advanced computational photography imaging and tailored AI tools, Full Field PBS gives clinical laboratories an unprecedented ability to capture digital scans with full-field view of the monolayer and feathered edge at 100X oil immersion resolution level. 

– The global market for hematology analyzers and reagents is currently $7.6 billion and is expected to reach $10.6 billion by 2025.


 Scopio Labs, a leading provider of Full Field Morphology (FFM), announced that it was granted FDA clearance to market and sell its X100 with Full Field Peripheral Blood Smear (Full Field PBS) Application, unlocking the potential of in vitro hematology diagnosis. Full Field PBS is also available in Europe with CE mark certification granted earlier this year.   

Why It Matters

Blood is one of the most foundational gateways to health information. Roughly 120,000 laboratories worldwide conduct 600 million PBS tests annually for the global population, predominantly via manual microscopes. Even with the adoption of digital tools, today’s solutions do not showcase all required regions of interest in a PBS slide, only capturing snapshots of cells. Consequently, technologists frequently default to the manual microscope for a more detailed examination of the raw data. 

AI-Powered Full Field Peripheral Blood Smear (Full Field PBS) Application 

FDA Clears First-in-World Hematology App, Unlocking Potential of Diagnosis

To help improve diagnostic accuracy leveraging novel computer vision tools, Full Field PBS gives clinical laboratories an unprecedented ability to capture digital scans using advanced computational photography imaging and tailored AI tools. The Full Field PBS utilizes adaptive monolayer identification in support of long and short smears and automates the analysis process by pre-classifying 200 white blood cells (WBC), providing platelet pre-estimate, and enabling RBC morphology evaluation.  Accelerating routine analysis, Full Field PBS includes a tailored decision support system for pre-classification of white blood cells into 16 classes, red blood cell morphology evaluations, platelet location and count.

“Understanding the challenges lab technicians, hematologists and hematopathologists face when evaluating blood samples containing large numbers of morphologically-unique cells in a timely fashion, we designed our solution specifically for hematology labs where we can improve quality of care, consistency of results and reduce review time,” said Scopio Labs’ CEO and Co-Founder, Itai Hayut. “We are thrilled to receive FDA clearance following the successful completion of a multi-center study, as we bring our innovative solution to laboratories around the U.S. to help improve the outcome of diagnosis and care.”  

Recent Traction

Earlier this year, the company closed a $16 million Series B funding round, bringing total funding to $30 million. Scopio Labs is setting its sights on transforming all hematology applications, including bone marrow aspirates (BMA) and body fluids. With a robust product development pipeline, and the ability to detect morphological events on a cellular and subcellular scale, Scopio Labs will open the door for morphology-based diagnostics, disease monitoring and treatment adjustment for various blood cancers.  

RELATED:   20 COVID-19 Predictions and Trends for 2021 - Executive Roundup

Tagged With: AI, decision support, FDA, FDA Clearance, foundational

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

« CareLinx, Doctor On Demand Partner to Bring In-Home Virtual Care to Seniors
Holy Name, Sheba Medical Center Partner to Develop Digital Health Solutions »

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Recent Articles

  • Hurdle Secures $5M for Digital Mental Health Platform for People of Color

    Hurdle Secures $5M for Digital Mental Health Platform for People of Color

    ... more
  • West Virginia Launches Nation’s First Statewide COVID-19 Vaccine Distribution Deployment

    West Virginia Launches Nation’s First Statewide COVID-19 Vaccine Distribution

    ... more
  • Onyx, AMA Innovations Form Collaboration to Build FHIR-Based Messaging

    Onyx, AMA Innovations Form Collaboration to Build FHIR-Based Messaging

    ... more
  • op 5 business opportunities for digital health companies in 2021. Where is the money?

    Top 5 Business Opportunities for Digital Health Companies in 2021. Where Is The Money?

    ... more

Most Read

  • 30 Executives Share Top Healthcare Predictions & Trends to Watch in 2021 30 Executives Share Top Healthcare Predictions & Trends to Watch in 2021
  • Intelligent Automation of the Revenue Cycle: How an Integrated Platform Approach Yields Financial Results Intelligent Automation of the Revenue Cycle: How an Integrated Platform Approach Yields Financial Results
  • 20 COVID-19 Predictions and Trends for 2021 - Executive Roundup 20 COVID-19 Predictions and Trends for 2021 – Executive Roundup
  • 16 COVID-19 Predictions and Trends for 2021 Executive Roundup 12-Available-COVID-19-Vaccine-Management-Solutions-to-Know-In-Depth-1 22 Recently Launched COVID-19 Vaccine Management Solutions to Know
  • FDA Approves COVID-19 Oral Fluid Test for Use Nationwide In-Depth: 32 FDA-Approved COVID-19 Testing Kits
  • Job Titles for Healthcare Executives The Top 9 Most In-Demand Medical Jobs
  • Fundamental Surgery Becomes First VR Surgical Training Simulation to Gain CPD Accreditation 18 Healthcare Augmented Reality and Virtual Reality Companies to Watch
  • West Virginia Launches Nation’s First Statewide COVID-19 Vaccine Distribution Deployment West Virginia Launches Nation’s First Statewide COVID-19 Vaccine Distribution
  • CVS Health Launches Senior Medical Alert System, Symphony CVS Health Launches Senior Medical Alert System, Symphony
  • op 5 business opportunities for digital health companies in 2021. Where is the money? Top 5 Business Opportunities for Digital Health Companies in 2021. Where Is The Money?

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2020 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2021. HIT Consultant Media. All Rights Reserved. Privacy Policy |